{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2019, Part 4

Activity Steps

Description

This is a knowledge-based activity directed at the pharmacist. 0431-0000-20-005-H04-P To successful complete the activity the learner is expected to pass the post-test with a score of 77% and fill out the closing evaluation.
Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Purpose of Activity

To review nine drugs recently approved by the FDA.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss indications for each drug discussed.
  2. List adverse reactions for each drug discussed.
  3. List pharmacy and/or nursing considerations for each drug discussed.
Price: $17.95

Credits:

  • ACPE 1.5 CH

Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Professions: Pharmacist
Test Code: N1119A-Pharm
Published: Nov 2019
Expires: 7/31/2023
Required Passing Score: 14/18 (77%)
Authors: Daniel A. Hussar, PhD
Dean Emeritus and Remington Professor of Pharmacy
Philadelphia College of Pharmacy, University of the Sciences
Specialties: Pharmacy, Risk Management
Topics: Patient Safety